Key Insights

Highlights

Treatment Research

3 treatments under study, led by Iol Master

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 2 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

Trial Status

Unknown2

Clinical Trials (2)

Showing 2 of 2 trials
NCT05366543UnknownPrimary

Errors of Refraction Among Primary School Children

NCT04816266UnknownPrimary

Comparative Study in Measuring Anterior Chamber Depth

Showing all 2 trials

Research Network

Common Treatments

  • Iol Master1
  • Visual Acuity Measurement1
  • Pentacam1

Active Sponsors

  • Minia University1
  • Assiut University1

Activity Timeline